10-K Filing

GUIDED THERAPEUTICS INC CIK: 924515 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001477932-24-001549`
Period End Date	20231231
Filing Date	20240328
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	gthp_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 48 Cash Flow Statement 80 Stockholders Equity 39

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$2.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$48.00K	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$591.00K	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$643.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$818.00K	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.31M	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$818.00K	USD	Point-in-time
Accounts receivable, net of allowance for credit losses of $2 and $48 at December 31, 2023 and 2022, respectively.	`AccountsReceivableNetCurrent`	$7.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net of allowance for credit losses of $2 and $48 at December 31, 2023 and 2022, respectively.	`AccountsReceivableNetCurrent`	$6.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Inventory, net of reserves of $818 at December 31, 2023 and 2022.	`InventoryNet`	$632.00K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Inventory, net of reserves of $818 at December 31, 2023 and 2022.	`InventoryNet`	$548.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	54.10M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	48.60M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$163.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$137.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	48.60M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.00M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	54.10M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.39M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$42.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$32.00K	USD	Point-in-time
Operating lease right-of-use assets, net of amortization	`OperatingLeaseRightOfUseAsset`	$227.00K	USD	Point-in-time
Operating lease right-of-use assets, net of amortization	`OperatingLeaseRightOfUseAsset`	$303.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$17.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$17.00K	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$276.00K	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$362.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.67M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.37M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.19M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.99M	USD	Point-in-time
Accounts payable, related parties	`AccountPayableRelatedPartiesCurrent`	$39.00K	USD	Point-in-time
Accounts payable, related parties	`AccountPayableRelatedPartiesCurrent`	$32.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.25M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$970.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$424.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$509.00K	USD	Point-in-time
Current portion of lease liability	`OperatingLeaseLiabilityCurrent`	$91.00K	USD	Point-in-time
Current portion of lease liability	`OperatingLeaseLiabilityCurrent`	$79.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$17.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	-	USD	Point-in-time
Current portion of long-term debt, related parties	`CurrentPortionOfLongTermDebtRelatedParties`	$504.00K	USD	Point-in-time
Current portion of long-term debt, related parties	`CurrentPortionOfLongTermDebtRelatedParties`	$39.00K	USD	Point-in-time
Short-term notes payable	`ShortTermNonBankLoansAndNotesPayable`	$59.00K	USD	Point-in-time
Short-term notes payable	`ShortTermNonBankLoansAndNotesPayable`	$57.00K	USD	Point-in-time
Short-term notes payable, related parties	`NotesPayableRelatedPartiesCurrent`	$1.00K	USD	Point-in-time
Short-term notes payable, related parties	`NotesPayableRelatedPartiesCurrent`	-	USD	Point-in-time
Short-term convertible debt	`ShortTermConvertibleNotesPayableIncludingNonconvertiblePenalty`	$230.00K	USD	Point-in-time
Short-term convertible debt	`ShortTermConvertibleNotesPayableIncludingNonconvertiblePenalty`	$1.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.81M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.87M	USD	Point-in-time
Long-term lease liability	`OperatingLeaseLiabilityNoncurrent`	$155.00K	USD	Point-in-time
Long-term lease liability	`OperatingLeaseLiabilityNoncurrent`	$246.00K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesNoncurrent`	$5.00K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Long-term convertible debt	`ConvertibleDebtNoncurrent`	$1.05M	USD	Point-in-time
Long-term convertible debt	`ConvertibleDebtNoncurrent`	-	USD	Point-in-time
Long-term debt, related parties	`CurrentPortionOfLongTermDebtRelatedPartiesNonCurrent`	$83.00K	USD	Point-in-time
Long-term debt, related parties	`CurrentPortionOfLongTermDebtRelatedPartiesNonCurrent`	$511.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.38M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$666.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$6.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.47M	USD	Point-in-time
Common stock, $.001 par value; 500,000 shares authorized, 54,105 and 48,596 shares issued and outstanding as of December 31, 2023 and 2022, respectively.	`CommonStockValue`	$3.44M	USD	Point-in-time
Common stock, $.001 par value; 500,000 shares authorized, 54,105 and 48,596 shares issued and outstanding as of December 31, 2023 and 2022, respectively.	`CommonStockValue`	$3.44M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$138.09M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$140.98M	USD	Point-in-time
Treasury stock at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-147.36M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-151.12M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityAmresh`	$-3.81M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityAmresh`	$-2.88M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$3.37M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.67M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`Revenues`	$13.00K	USD	Annual
Sales - devices and disposables	`Revenues`	$98.00K	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$81.00K	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$62.00K	USD	Annual
Gross profit (loss)	`GrossProfit`	$36.00K	USD	Annual
Gross profit (loss)	`GrossProfit`	$-68.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$228.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$77.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$268.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$181.00K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.00M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.01M	USD	Annual
Total operating expenses	`OperatingExpenses`	$3.49M	USD	Annual
Total operating expenses	`OperatingExpenses`	$3.27M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.33M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.46M	USD	Annual
Interest expense	`InterestExpense`	$278.00K	USD	Annual
Interest expense	`InterestExpense`	$582.00K	USD	Annual
Interest income	`InterestIncomeOperating`	$6.00K	USD	Annual
Interest income	`InterestIncomeOperating`	-	USD	Annual
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$5.00K	USD	Annual
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$27.00K	USD	Annual
Gain (Loss) from extinguishment of debt	`GainFromExtinguishmentOfDebt`	$-469.00K	USD	Annual
Gain (Loss) from extinguishment of debt	`GainFromExtinguishmentOfDebt`	$196.00K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$39.00K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$16.00K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.01M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-32.00K	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.34M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.49M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-4.34M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.49M	USD	Annual
Deemed dividend for warrant exchanges	`DeemedDividendForWarrantExchanges`	$-99.00K	USD	Annual
Deemed dividend for warrant exchanges	`DeemedDividendForWarrantExchanges`	-	USD	Annual
Preferred stock dividends	`DividendsPreferredStock`	$631.00K	USD	Annual
Preferred stock dividends	`DividendsPreferredStock`	$171.00K	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.97M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.76M	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.07	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.15	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-0.15	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-0.07	USD	Annual
Basic	`WeightedAverageNumberOfSharesIssuedBasic`	32.51M	shares	Annual
Basic	`WeightedAverageNumberOfSharesIssuedBasic`	51.13M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	32.51M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	51.13M	shares	Annual

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.49M	USD	Annual
Net loss	`ProfitLoss`	$-4.34M	USD	Annual
Bad debt expense	`BadDebtExpense`	$23.00K	USD	Annual
Bad debt expense	`BadDebtExpense`	$2.00K	USD	Annual
Inventory reserve	`InventoryReserve`	$81.00K	USD	Annual
Inventory reserve	`InventoryReserve`	-	USD	Annual
Depreciation	`Depreciation`	$4.00K	USD	Annual
Depreciation	`Depreciation`	$9.00K	USD	Annual
Amortization of debt issuance costs and discounts	`AmortizationOfFinancingCostsAndDiscounts`	$143.00K	USD	Annual
Amortization of debt issuance costs and discounts	`AmortizationOfFinancingCostsAndDiscounts`	$130.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.38M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.81M	USD	Annual
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$5.00K	USD	Annual
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$27.00K	USD	Annual
Amortization of lease right-of-use-asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$76.00K	USD	Annual
Amortization of lease right-of-use-asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$68.00K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$655.00K	USD	Annual
Gain from forgiveness of debt	`GainFromForgivenessOfDebt`	$196.00K	USD	Annual
Gain from forgiveness of debt	`GainFromForgivenessOfDebt`	$186.00K	USD	Annual
Other non-cash expenses	`OtherNoncashIncomeExpense`	$172.00K	USD	Annual
Other non-cash expenses	`OtherNoncashIncomeExpense`	$26.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-16.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$58.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$84.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$103.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$363.00K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$122.00K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$43.00K	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-79.00K	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-67.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-85.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$172.00K	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-1.75M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-1.48M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.00K	USD	Annual
Proceeds from warrant exercises	`ProceedsFromWarrantExercises`	$436.00K	USD	Annual
Proceeds from warrant exercises	`ProceedsFromWarrantExercises`	$532.00K	USD	Annual
Payments made on notes payable	`RepaymentsOfNotesPayable`	$412.00K	USD	Annual
Payments made on notes payable	`RepaymentsOfNotesPayable`	$540.00K	USD	Annual
Proceeds from issuance of common stock, net of costs	`ProceedsFromIssuanceOfCommonStock`	$1.39M	USD	Annual
Proceeds from issuance of common stock, net of costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of warrants, net of costs	`ProceedsFromIssuancesOfWarrantsNetOfCosts`	$1.80M	USD	Annual
Proceeds from issuance of warrants, net of costs	`ProceedsFromIssuancesOfWarrantsNetOfCosts`	-	USD	Annual
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$3.18M	USD	Annual
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$24.00K	USD	Annual
NET CHANGE IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.72M	USD	Annual
NET CHANGE IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.67M	USD	Annual
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$591.00K	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$643.00K	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.31M	USD	Point-in-time
CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$591.00K	USD	Point-in-time
CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$643.00K	USD	Point-in-time
CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.31M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$149.00K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$107.00K	USD	Annual
Dividends on preferred stock	`DividendsPreferredStockStock`	$631.00K	USD	Annual
Dividends on preferred stock	`DividendsPreferredStockStock`	$171.00K	USD	Annual
Deemed dividends for warrant exchanges	`DeemedDividendsForWarrantExchanges`	-	USD	Annual
Deemed dividends for warrant exchanges	`DeemedDividendsForWarrantExchanges`	$99.00K	USD	Annual
Settlement of interest through common stock issuance	`SettlementOfInterestThroughCommonStockIssuance`	$119.00K	USD	Annual
Settlement of interest through common stock issuance	`SettlementOfInterestThroughCommonStockIssuance`	$151.00K	USD	Annual
Settlement of dividends through common stock issuance	`SettlementOfDividendsThroughCommonStockIssuance`	$730.00K	USD	Annual
Settlement of dividends through common stock issuance	`SettlementOfDividendsThroughCommonStockIssuance`	$173.00K	USD	Annual
Settlement of previously accrued professional fees through common stock issuance	`SettlementOfPreviouslyAccruedProfessionalFeesThroughCommonStockIssuance`	-	USD	Annual
Settlement of previously accrued professional fees through common stock issuance	`SettlementOfPreviouslyAccruedProfessionalFeesThroughCommonStockIssuance`	$168.00K	USD	Annual
Conversion of Series C-2 preferred shares into common stock	`ConversionOfSeriesC2PreferredSharesIntoCommonStock`	$92.00K	USD	Annual
Conversion of Series C-2 preferred shares into common stock	`ConversionOfSeriesC2PreferredSharesIntoCommonStock`	-	USD	Annual
Conversion of Series D preferred shares into common stock	`ConversionOfSeriesDPreferredSharesIntoCommonStock`	$118.00K	USD	Annual
Conversion of Series D preferred shares into common stock	`ConversionOfSeriesDPreferredSharesIntoCommonStock`	-	USD	Annual
Conversion of Series E preferred shares into common stock	`ConversionOfSeriesEPreferredSharesIntoCommonStock`	$5.00K	USD	Annual
Conversion of Series E preferred shares into common stock	`ConversionOfSeriesEPreferredSharesIntoCommonStock`	$800.00K	USD	Annual
Conversion of Series F preferred shares into common stock	`ConversionOfSeriesFPreferredSharesIntoCommonStock`	$42.00K	USD	Annual
Conversion of Series F preferred shares into common stock	`ConversionOfSeriesFPreferredSharesIntoCommonStock`	$308.00K	USD	Annual
Conversion of Series F-2 preferred shares into common stock	`ConversionOfSeriesF2PreferredSharesIntoCommonStock`	$2.47M	USD	Annual
Conversion of Series F-2 preferred shares into common stock	`ConversionOfSeriesF2PreferredSharesIntoCommonStock`	$14.00K	USD	Annual
Directors and Officers insurance obtained with financing	`DirectorsAndOfficersInsuranceObtainedWithFinancing`	$129.00K	USD	Annual
Directors and Officers insurance obtained with financing	`DirectorsAndOfficersInsuranceObtainedWithFinancing`	$124.00K	USD	Annual

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Balance, amount	`StockholdersEquity`	$-5.45M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-3.81M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-2.88M	USD	Point-in-time
Common stock warrants exercised, amount	`CommonStockWarrantsExercisedAmount`	$846.00K	USD	Annual
Common stock warrants exercised, amount	`CommonStockWarrantsExercisedAmount`	$472.00K	USD	Annual
Issuances of common stock to investors, amount	`IssuancesOfCommonStockToInvestorsAmount`	$1.43M	USD	Annual
Issuances of warrants to investors	`IssuancesOfWarrantsToInvestors`	$1.79M	USD	Annual
Issuance of common stock for payment of Series D preferred dividends, amount	`IssuanceOfCommonStockForPaymentOfSeriesDPreferredDividendsAmount`	$47.00K	USD	Annual
Issuance of common stock for payment of Series D preferred dividends, amount	`IssuanceOfCommonStockForPaymentOfSeriesDPreferredDividendsAmount`	$30.00K	USD	Annual
Issuance of common stock for payment of Series E preferred dividends, amount	`IssuanceOfCommonStockForPaymentOfSeriesEPreferredDividendsAmount`	$102.00K	USD	Annual
Issuance of common stock for payment of Series E preferred dividends, amount	`IssuanceOfCommonStockForPaymentOfSeriesEPreferredDividendsAmount`	$61.00K	USD	Annual
Issuance of common stock for payment of Series F preferred dividends, amount	`IssuanceOfCommonStockForPaymentOfSeriesFPreferredDividendsAmount`	$107.00K	USD	Annual
Issuance of common stock for payment of Series F preferred dividends, amount	`IssuanceOfCommonStockForPaymentOfSeriesFPreferredDividendsAmount`	$53.00K	USD	Annual
Issuance of common stock for payment of Series F-2 preferred dividends, amount	`IssuanceOfCommonStockForPaymentOfSeriesF2PreferredDividendsAmount`	$29.00K	USD	Annual
Issuance of common stock for payment of Series F-2 preferred dividends, amount	`IssuanceOfCommonStockForPaymentOfSeriesF2PreferredDividendsAmount`	$75.00K	USD	Annual
Issuance of common stock for payment of interest, amount	`IssuanceOfCommonStockForPaymentOfInterestAmount`	$150.00K	USD	Annual
Issuance of common stock for payment of interest, amount	`IssuanceOfCommonStockForPaymentOfInterestAmount`	$119.00K	USD	Annual
Issuance of common stock for Series F and Series F-2 one-time 15% dividends, amount	`IssuanceOfCommonStockForSeriesFAndSeriesF2OneTime15DividendsAmount`	$400.00K	USD	Annual
Conversion of Series C-2 preferred stock to common stock, amount	`ConversionOfSeriesC2PreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series D preferred stock to common stock, amount	`ConversionOfSeriesDPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series E preferred stock to common stock, amount	`ConversionOfSeriesEPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series E preferred stock to common stock, amount	`ConversionOfSeriesEPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series F preferred stock to common stock, amount	`ConversionOfSeriesFPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series F preferred stock to common stock, amount	`ConversionOfSeriesFPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series F-2 preferred stock to common stock, amount	`ConversionOfSeriesF2PreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series F-2 preferred stock to common stock, amount	`ConversionOfSeriesF2PreferredStockToCommonStockAmount`	-	USD	Annual
Stock-based compensation	`Stockbasedcompensationn`	$1.81M	USD	Annual
Stock-based compensation	`Stockbasedcompensationn`	$176.00K	USD	Annual
Issuances of warrants to consultants	`IssuancesOfWarrantsToConsultants`	$1.20M	USD	Annual
Impact of Auctus exchange, amount	`ImpactOfAuctusExchangeAmount`	$1.20M	USD	Annual
Accrued preferred dividends	`Accruedpreferreddividends`	$-172.00K	USD	Annual
Accrued preferred dividends	`Accruedpreferreddividends`	$-631.00K	USD	Annual
Net loss	`NetIncomeLosses`	$-4.34M	USD	Annual
Net loss	`NetIncomeLosses`	$-3.49M	USD	Annual
Settlement of previously accrued professional fees through common stock issuance, amount	`SettlementOfPreviouslyAccruedProfessionalFeesThroughCommonStockIssuanceAmount`	$168.00K	USD	Annual
Impact of warrant exchanges	`ImpactOfWarrantExchanges`	-	USD	Annual
Balance, amount	`StockholdersEquity`	$-5.45M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-3.81M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-2.88M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.